A Study to Test How Well Different Doses of BI 1584862 Are Tolerated by Healthy Men
Clinical trial NCT06006598 · COMPLETED
Trial details
- NCT number
- NCT06006598
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-28
- Primary completion
- 2024-05-05
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.